About
Kristen Fortney, PhD, is co-founder and CEO of BioAge Labs, a clinical-stage biotechnology company developing therapies for metabolic diseases by targeting the biology of human aging. Her background is in aging research, systems biology, and bioinformatics, with doctoral training at the University of Toronto and postdoctoral work at Stanford. Public disclosures also show she is an angel investor in at least Ochre Bio and Bluenote, while remaining a visible mentor and industry voice in longevity biotech.
Areas of interest
longevitybiotechaging biologymetabolic diseaseobesitycardiovascular diseaseretinal diseasebioinformaticsAI-driven drug discoveryRNA therapeuticslife sciences software